StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)

Close on Nov 18, 2026Market cap $46.20MP/E –Yield –

Mereo BioPharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Mereo BioPharma's enterprise value was $19.03M on Nov 11, 2026, against $246.64M a year earlier. Over the last 5 years it ranged from $1.80M to $582.12M, with a median of $124.38M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$19.03M+11.2%
2025Dec 31, 2025$17.11M-96.1%
2024Dec 31, 2024$434.04M+106.2%
2023Dec 29, 2023$210.49M+152.7%
2022Dec 30, 2022$83.29M-23.2%
2021Dec 31, 2021$108.47M+69.4%
2020Dec 31, 2020$64.03M-99.9%
2019Dec 31, 2019$46.67B+33813324.8%
2018Apr 25, 2018$138.03K+54.1%
2017Apr 28, 2017$89.58K–

More Mereo BioPharma figures

See a number that looks wrong?